![]() LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. | ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. | ![]() Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ||
Founding Date | Founding Date 1985 | Founding Date 2015 | Founding Date 1996 | Founding Date 2004 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Los Angeles, US HQ | Locations Houston, US HQ | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US |
Employees | Employees 385% decrease | Employees 814% increase | Employees 433% increase | Employees 194362% increase |
Valuation ($) | Valuation ($) 901.1 k | Valuation ($) N/A | Valuation ($) 129.4 m | Valuation ($) 515.9 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) |
Net income | Net income ($1.6m) (FY, 2024) | Net income N/A | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) |
ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism.
View company
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company
UroGen Pharma is a clinical-stage biopharmaceutical company.
View company